Shell buys bigger stake in biofuel enzyme co. Codexis

Shell buys bigger stake in biofuel enzyme co. Codexis

In an effort to commercialize next-generation biofuels by 2013, Royal Dutch Shell has taken a bigger stake in Redwood City, Calif. biofuel technology company Codexis. The two companies struck a five-year deal in 2007 that infused Codexis with $30 million and gave Shell a seat… Continue Reading

Pelikan closes $25M for handheld diagnostics

Pelikan Technologies, maker of medical devices for diagnosing and monitoring diabetes, just brought in $25 million from undiclosed investors, reports VentureWire. Based in Palo Alto, Calif., the company spun out of Agilent Technologies in 2001 with the launch of its Pelikan Sun line, an electronic… Continue Reading

Broncus inhales $38M to treat lung disease, eyes IPO

Broncus Technologies, developer of devices to treat emphysema and other lung ailments, may make a second run at going public after bringing in $38 million in seventh-round funding to break even, reports VentureWire. The Mountain View, Calif. company first filed for a $75 million IPO… Continue Reading

Pelikan scoops up $12.5M for diabetes diagnostics

Pelikan Technologies, maker of diagnostic and health-monitoring devices that can be used by regular people, nabbed a $12.5 million tranche of an expected $25 million seventh round of funding, according to VentureWire. Its flagship product, the handheld diabetes tester Pelikan Sun, is already on the… Continue Reading

Revance absorbs $8M for topical Botox

Aesthetic drug developer Revance Therapeutics has landed $8 million in venture debt financing from Leader Ventures and Horizon Technology Finance. The money will be used to push its lead compound, a topical form of botulinum toxin type A (popularly known as Botox), through clinical stage… Continue Reading

S*BIO takes $26M for cancer therapeutics

Pharmaceutical company S*BIO announced today that it raised $26 million in second-round funding to help push two new cancer treatment candidates through a second phase of clinical trials. Aravis Venture Associates and Bio*One Capital led the round, which also included Lacuna Apo BioTech and Zurcher… Continue Reading

Pelikan Tech to push “finger friendly” diabetes testing

Pelikan Tech to push “finger friendly” diabetes testing

One of the constant but unavoidable challenges in trying to control diabetes is the frequent need to test blood-sugar levels by sticking a needle into a fingertip — a step that tells diabetics when they need a snack (to raise blood glucose) or a shot… Continue Reading